Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials (Q36302240)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials |
scientific article |
Statements
1 reference
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials (English)
1 reference
Douglas Hough
1 reference
Dafna Gladman
1 reference
Andrea Doria
1 reference
Michelle A Petri
1 reference
Joan T Merrill
1 reference
Susan Manzi
1 reference
Ellen M Ginzler
1 reference
Jorge Sánchez-Guerrero
1 reference
Richard Furie
1 reference
Sandra V Navarra
1 reference
David P D'Cruz
1 reference
Simon Cooper
1 reference
Z John Zhong
1 reference
William Freimuth
1 reference
BLISS-52 and BLISS-76 Study Groups
1 reference
1 reference
Identifiers
1 reference